In section Releases

Valmont Debuts Epigenetic Skin Program as Longevity Market Expands

With the global longevity economy projected to hit $740 billion this year, Swiss skincare house Valmont is shifting from topical beauty to biological optimization. The brand’s new program, The Art of Longevity, integrates genetic testing and lifestyle analysis into a personalized wellness blueprint designed to bridge cellular science and daily self-care.

Valmont Debuts Epigenetic Skin Program as Longevity Market Expands

Developed by CEO Sophie Vann Guillon alongside longevity specialist Dr. Filippo Ongaro, the initiative moves beyond traditional facials by examining 146 genetic variations across 90 genes. Participants undergo a comprehensive assessment covering cell regeneration, oxidative stress, and inflammation, which is then synthesized with a 40-question lifestyle survey. The resulting Signature Longevity Blueprint provides custom guidance on nutrition, sleep, mobility, and mental resilience, alongside specialized treatments like Kobido massage and lymphatic drainage.

Valmont has implemented the program at La Maison Valmont locations in Madrid, Munich, and New York’s The Carlyle Hotel, with a Beverly Hills expansion scheduled for 2027. To address privacy concerns regarding biological data, the company partnered with BMR Genomics to ensure all genetic information is encrypted and processed in compliance with GDPR standards. The blueprint experience carries a $1,500 price tag, with supplementary mind and body treatments starting at $295. By positioning skincare as a component of integrative health, Valmont aims to capture a growing demographic seeking science-backed, personalized aging solutions.

Share:on TelegramXFacebook

Subscribe to our newsletter

Once a week — the best stories from our editors, no ads or push notifications. Delivered Sunday morning.

Comments (0)

Leave a comment

No comments yet. Be the first!